← Leaderboards
Nicholas J Maragakis
Johns Hopkins University
$2,959,620
Attributed
$2,959,620
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2010–24$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,558,622 · 4
By mechanism
U01$3,599,002 · 1
R01$1,925,456 · 1
K08$588,664 · 1
R21$445,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Ted M. Dawson$31,695,689
- Jeff W Bulte$21,671,493
- Russell L Margolis$10,931,342
- Veronica Colomer$1,553,250
- Elizabeth O'Hearn$1,739,193
Others in their field
Top investigators on “Glutamates”
- Merit E Cudkowicz · Massachusetts General Hospital$40,827,833
- Alan G. Barbour · University Of California Irvine$39,660,285
- Scott W Woods · Yale University$33,212,495
- Paul F Worley · Johns Hopkins University$32,678,609
- Richard L Huganir · Johns Hopkins University$30,324,803
- John M Kane · Long Island Jewish Medical Center$28,729,148
Research focus
GlutamatesIn VitroSpinal CordAmyotrophic Lateral SclerosisCellsEventMotor NeuronsNeuronsDisease ProgressionDesignCessation Of LifeEnvironmentExtracellularAstrocytesCoculture TechniquesDoseFunctional DisorderCoupledBrainConnexinsBuffersBiologyBlood VesselsBehavioral
Grant awards (15)
Modulating an Astrocyte Hemichannel to Delay Spatial and Temporal Progression in ALS.$373,268
R01 · FY2024 · NS · contact PI
Modulating an Astrocyte Hemichannel to Delay Spatial and Temporal Progression in ALS.$384,813
R01 · FY2023 · NS · contact PI
Modulating an Astrocyte Hemichannel to Delay Spatial and Temporal Progression in ALS.$384,813
R01 · FY2022 · NS · contact PI
Modulating an Astrocyte Hemichannel to Delay Spatial and Temporal Progression in ALS.$384,820
R01 · FY2021 · NS · contact PI
Modulating an Astrocyte Hemichannel to Delay Spatial and Temporal Progression in ALS.$397,742
R01 · FY2020 · NS · contact PI
Investigating the contributions of astrocyte gap junctions to ALS disease progression$202,500
R21 · FY2016 · NS · contact PI
Investigating the contributions of astrocyte gap junctions to ALS disease progression$243,000
R21 · FY2015 · NS · contact PI
Glial Progenitor Cells for Treatment of ALS$1,309,432
U01 · FY2014 · NS · contact PI
Glial Progenitor Cells for Treatment of ALS$1,317,241
U01 · FY2012 · NS · contact PI
Glial Progenitor Cells for Treatment of ALS$972,329
U01 · FY2010 · NS · contact PI
The Glutamate Transporter EAAT4 in Purkinje Cell Biology$172,422
K08 · FY2003 · NS
The Glutamate Transporter EAAT4 in Purkinje Cell Biology$172,422
K08 · FY2002 · NS
THE GLUTAMATE TRANSPORTER EAAT4 IN PUKINJE CELL BIOLOGY$114,987
K08 · FY2001 · NS
THE GLUTAMATE TRANSPORTER EAAT4 IN PUKINJE CELL BIOLOGY$114,987
K08 · FY2000 · NS
GLUTAMATE TRANSPORTER EAAT4 IN PURKINJE CELL BIOLOGY$13,846
K08 · FY2000 · NS